Cargando…
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
Evaluation of potential immunity against the novel severe acute respiratory syndrome (SARS) coronavirus that emerged in 2019 (SARS-CoV-2) is essential for health, as well as social and economic recovery. Generation of antibody response to SARS-CoV-2 (seroconversion) may inform on acquired immunity f...
Autores principales: | McAndrews, Kathleen M., Dowlatshahi, Dara P., Dai, Jianli, Becker, Lisa M., Hensel, Janine, Snowden, Laura M., Leveille, Jennifer M., Brunner, Michael R., Holden, Kylie W., Hopkins, Nikolas S., Harris, Alexandria M., Kumpati, Jerusha, Whitt, Michael A., Lee, J. Jack, Ostrosky-Zeichner, Luis L., Papanna, Ramesha, LeBleu, Valerie S., Allison, James P., Kalluri, Raghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526535/ https://www.ncbi.nlm.nih.gov/pubmed/32796155 http://dx.doi.org/10.1172/jci.insight.142386 |
Ejemplares similares
-
Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses
por: Hensel, Janine, et al.
Publicado: (2020) -
Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2021) -
A peek into cancer-associated fibroblasts: origins, functions and translational impact
por: LeBleu, Valerie S., et al.
Publicado: (2018) -
Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer
por: McAndrews, Kathleen M, et al.
Publicado: (2021) -
Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity
por: Kugeratski, Fernanda G., et al.
Publicado: (2023)